首页> 外文期刊>Current vascular pharmacology >Is there Sex-related Outcome Difference According to Oral P2Y12 Inhibitors in Patients with Acute Coronary Syndromes? A Systematic Review and Meta-Analysis of 107,126 Patients
【24h】

Is there Sex-related Outcome Difference According to Oral P2Y12 Inhibitors in Patients with Acute Coronary Syndromes? A Systematic Review and Meta-Analysis of 107,126 Patients

机译:根据口服 P2Y12 抑制剂在急性冠脉综合征患者中是否存在性别相关结果差异?对 107,126 名患者的系统评价和荟萃分析

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Background and Objectives: The majority of patients included in trials of anti-platelet therapy are male. This systematic review and meta-analysis aimed to determine whether, in addition to aspirin, P2Y(12) blockade is beneficial in both women and men with acute coronary syndromes.
机译:背景和目的:抗血小板治疗试验中纳入的大多数患者是男性。本系统评价和荟萃分析旨在确定除阿司匹林外,P2Y(12)阻断剂是否对患有急性冠脉综合征的女性和男性有益。

著录项

相似文献

  • 外文文献
  • 中文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号